C5i IPO 2026: DRHP, Issue Size, Financials & Latest Updates

C5i, formerly known as Course5 Intelligence, is preparing to file its Draft Red Herring Prospectus (DRHP) with SEBI for a mainboard IPO estimated at Rs 1,000 crore to Rs 1,500 crore. The company is a pure-play enterprise AI and data analytics solutions provider backed by institutional investors including 360 ONE Asset, Nuvama Wealth, and Carnelian Asset Advisors. ICICI Securities is the appointed Book Running Lead Manager (BRLM) for the offering.

The filing is expected soon, with the listing targeted on both BSE and NSE.

📋 Table of Contents

C5i IPO Key Details

Note: Price band, lot size, and IPO dates will be confirmed after SEBI issues its observation letter on the DRHP.

What Is C5i?

C5i is a specialized enterprise AI and data analytics company that helps large global corporations build AI-driven decision-making systems. Its clients include Fortune 500 companies across sectors such as banking, life sciences, and consumer packaged goods (CPG).

The company was originally incorporated in 2000 as Cross-Tab.com, later rebranded to Course5 Intelligence, and recently refreshed its identity to C5i to reflect its focus on generative AI, machine learning, and advanced data platforms.

Unlike traditional IT services companies that grow by adding headcount, C5i operates on an IP-driven model. It embeds proprietary software platforms into client systems, which allows it to scale revenues without a proportional increase in employee costs. This structural difference is important for investors evaluating margin potential.

C5i IPO: Financial Performance (FY25)

C5i reported the following standalone financials for the fiscal year ended March 31, 2025:

• Total Revenue from Operations: Rs 566 crore
• Profit After Tax (PAT): Rs 48 crore

The company is profitable at the net level, which separates it from many technology startups that are still loss-making at the time of their IPO. Maintaining profitability while funding two large international acquisitions is a positive signal for investors assessing financial discipline.

Note: Consolidated financials including Analytic Edge and Datavid will be available in the final RHP once SEBI review is complete.

Two Major Acquisitions Reshaping the Business

Analytic Edge Acquisition (FY25)

C5i acquired Analytic Edge, a Singapore-headquartered AI-based marketing analytics company, in a deal estimated at $30 million to $40 million. Analytic Edge operates across the US, Europe, Japan, and Brazil, and brings its proprietary "Qube" platform into C5i's product suite.

Qube provides real-time marketing mix modeling, pricing intelligence, and budget optimization tools, primarily for CPG companies. This adds a product-driven, recurring revenue stream to C5i's existing services business.

Datavid Acquisition (March 2026)

In March 2026, C5i entered into a definitive agreement to fully acquire UK-based data and AI specialist Datavid in an all-cash transaction valued at $40 million to $50 million.

Datavid specializes in graph data engineering and knowledge graphs. Knowledge graphs help large language models (LLMs) understand the real connections between different enterprise data sources, which reduces AI errors in regulated industries like life sciences and healthcare. This acquisition strengthens C5i's ability to deploy reliable AI solutions in sectors where data accuracy is critical.

Combined, the two acquisitions represent a total outlay of approximately $70 million to $90 million, funded with support from institutional backers.

C5i IPO: Revenue Outlook Toward FY27

With both acquisitions now part of the consolidated entity, C5i is targeting a revenue run rate exceeding Rs 1,000 crore by FY27. This would represent significant growth from the FY25 standalone base of Rs 566 crore.

Whether the company can maintain its current profit margins during the integration phase will be a key factor investors should monitor in the final RHP financials.

C5i IPO: Core Technology Platforms

C5i's primary technology product is its Agent5i platform, which is built around agentic AI architecture. Unlike standard AI chatbots that respond to user queries, agentic AI systems can take autonomous actions across complex enterprise workflows.

Practical examples include mapping supplier networks, predicting logistics delays, and automatically adjusting inventory levels. Combined with domain expertise in banking, life sciences, and CPG, this positions C5i as a higher-value partner compared to generic IT services providers.

C5i IPO: Risks Investors Should Consider

No IPO review is complete without an honest assessment of structural or macro risks:

C5i IPO: Institutional Backing

The company's private equity investor base includes marquee institutional groups:

• 360 ONE Asset (formerly IIFL Wealth)
• Nuvama Wealth
• Carnelian Asset Advisors

The presence of established institutional investors provides some confidence that the company's financial decisions and acquisition strategy have been reviewed by experienced fund managers. However, investors should note that institutional backing does not eliminate absolute investment risk.

C5i IPO: Expected Lot Size and Application Details

The final lot size and price band will be confirmed only after SEBI issues its observation letter on the DRHP. Based on standard mainboard rules for profitable companies, the following is expected:

• Minimum Retail Application: Approximately Rs 14,000 to Rs 15,000 (one lot)
• Minimum Small HNI (sNII) Application: Rs 2,01,000 and above
• Listing Exchange: BSE and NSE mainboard platforms

This page will be updated with confirmed values once the RHP is formalized.

C5i IPO GMP (Grey Market Premium)

Grey market trading in C5i IPO shares has not yet started, as the draft Red Herring Prospectus is yet to be formally accepted by SEBI. GMP tracking metrics will initiate and update dynamically once the public subscription dates open.

For live GMP updates across all active IPOs, visit the IPOwiz Live IPO GMP Tracker.

What Investors Should Watch Before Applying

• DRHP Filing Date: The DRHP submission to SEBI is the first formal milestone. Once filed, the 600-plus page document will contain audited consolidated financials, risk factors, and the exact use of proceeds.
• SEBI Observation Letter: SEBI typically takes 30 to 75 days to issue its observations after DRHP filing. The IPO cannot open until this clearance is received.
• Consolidated Financials: The RHP will include financials that consolidate Analytic Edge and Datavid. Investors should review these carefully to assess the true post-acquisition margin profile.
• Valuation Comparison: Compare the final price band against listed peers in the enterprise technology and AI analytics space before making an application decision.
• GMP Trend: Once the IPO opens, track the grey market premium trend as one indicator of investor sentiment. Remember that GMP is not a guarantee of listing gains.

Frequently Asked Questions